Chromocell Therapeutics Corporation (CHRO)

USD 0.59

(-4.76%)

Total Debt Summary of Chromocell Therapeutics Corporation

  • Chromocell Therapeutics Corporation's latest annual total debt in 2023 was 1.26 Million USD , up 134.75% from previous year.
  • Chromocell Therapeutics Corporation's latest quarterly total debt in 2024 Q2 was 1.58 Million USD , down 0.0% from previous quarter.
  • Chromocell Therapeutics Corporation reported annual total debt of 540.43 Thousand USD in 2022, down -50.87% from previous year.
  • Chromocell Therapeutics Corporation reported annual total debt of 1.09 Million USD in 2021, up 354.91% from previous year.
  • Chromocell Therapeutics Corporation reported quarterly total debt of 1.58 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Chromocell Therapeutics Corporation reported quarterly total debt of 1.26 Million USD for 2023 FY, up 134.75% from previous quarter.

Annual Total Debt Chart of Chromocell Therapeutics Corporation (2023 - 2020)

Historical Annual Total Debt of Chromocell Therapeutics Corporation (2023 - 2020)

Year Total Debt Total Debt Growth
2023 1.26 Million USD 134.75%
2022 540.43 Thousand USD -50.87%
2021 1.09 Million USD 354.91%
2020 241.79 Thousand USD 0.0%

Peer Total Debt Comparison of Chromocell Therapeutics Corporation

Name Total Debt Total Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD -156.3%
Ampio Pharmaceuticals, Inc. 274 Thousand USD -363.024%
Armata Pharmaceuticals, Inc. 120.37 Million USD 98.946%
Actinium Pharmaceuticals, Inc. 2.11 Million USD 39.958%
Azitra, Inc. 885.94 Thousand USD -43.201%
Can-Fite BioPharma Ltd. 39.99 Thousand USD -3071.792%
Calidi Biotherapeutics, Inc. 7.23 Million USD 82.467%
CEL-SCI Corporation 13.57 Million USD 90.652%
iBio, Inc. 4.46 Million USD 71.554%
Lineage Cell Therapeutics, Inc. 2.95 Million USD 57.023%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. 3.55 Million USD 64.323%
Navidea Biopharmaceuticals, Inc. 2.43 Million USD 47.883%
NovaBay Pharmaceuticals, Inc. 2.74 Million USD 53.698%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. 312.7 Thousand USD -305.716%
BiomX Inc. 15.09 Million USD 91.594%
BiomX Inc. 15.09 Million USD 91.594%
Protalix BioTherapeutics, Inc. 26.28 Million USD 95.173%
Palatin Technologies, Inc. 590.33 Thousand USD -114.908%
Scorpius Holdings, Inc. 14.04 Million USD 90.965%